MIR376C
gene geneOn this page
Also known as hsa-mir-368hsa-mir-376c
Summary
MIR376C (microRNA 376c, HGNC:31782) is a microRNA gene on chromosome 14q32.31.
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.
Source: NCBI Gene 442913 — RefSeq curated summary.
At a glance
- Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31782 |
| Approved symbol | MIR376C |
| Name | microRNA 376c |
| Location | 14q32.31 |
| Locus type | RNA, micro |
| Status | Approved |
| Aliases | hsa-mir-368, hsa-mir-376c |
| Ensembl gene | ENSG00000283279 |
| Ensembl biotype | miRNA |
| OMIM | 610983 |
| Entrez | 442913 |
| RNAcentral | URS000075AAAD — miRNA, 66 nt, 5 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 miRNA
ENST00000607441
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000607441 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003699182 | 101039690 | 101039755 |
Expression profiles
Bgee: expression breadth broad, 52 present calls, max score 82.75.
Top tissues by expression
52 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| placenta | UBERON:0001987 | 82.75 | gold quality |
| adrenal tissue | UBERON:0018303 | 82.32 | gold quality |
| heart | UBERON:0000948 | 80.88 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.51 | gold quality |
| lung | UBERON:0002048 | 79.10 | gold quality |
| muscle of leg | UBERON:0001383 | 78.56 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 73.30 | gold quality |
| gastrocnemius | UBERON:0001388 | 73.27 | gold quality |
| islet of Langerhans | UBERON:0000006 | 72.12 | gold quality |
| intestine | UBERON:0000160 | 71.77 | gold quality |
| putamen | UBERON:0001874 | 71.66 | gold quality |
| Ammon’s horn | UBERON:0001954 | 69.63 | gold quality |
| blood | UBERON:0000178 | 69.40 | gold quality |
| colon | UBERON:0001155 | 69.23 | gold quality |
| left adrenal gland | UBERON:0001234 | 69.08 | gold quality |
| esophagus mucosa | UBERON:0002469 | 69.04 | gold quality |
| caudate nucleus | UBERON:0001873 | 68.43 | gold quality |
| right lobe of liver | UBERON:0001114 | 68.40 | gold quality |
| liver | UBERON:0002107 | 68.35 | gold quality |
| ascending aorta | UBERON:0001496 | 68.10 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 67.55 | gold quality |
| substantia nigra | UBERON:0002038 | 67.12 | gold quality |
| skin of leg | UBERON:0001511 | 65.95 | gold quality |
| right frontal lobe | UBERON:0002810 | 65.82 | gold quality |
| frontal lobe | UBERON:0016525 | 65.81 | gold quality |
| tibial artery | UBERON:0007610 | 65.65 | gold quality |
| ovary | UBERON:0000992 | 65.19 | gold quality |
| left ovary | UBERON:0002119 | 65.19 | gold quality |
| brain | UBERON:0000955 | 65.18 | gold quality |
| renal glomerulus | UBERON:0000074 | 65.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.32 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 24)
- miR-376c promotes ovarian cancer cell proliferation,survival and spheroid formation (PMID:21224400)
- down-regulation of mir-376a and mir-376c may contribute to IGF1R over-expression and to aberrant negative regulation of this signaling pathway in melanoma, thus promoting tumorigenesis and metastasis. (PMID:22747855)
- Upregulation of plasma MIR376C is associated with breast cancer. (PMID:22927033)
- the role of miR-376c in regulating osteosarcoma cell growth via miR-376c/TGF-alpha axis (PMID:23631646)
- Epigenetic repression of miR-376c accelerated EGF-dependent cell migration through its target GRB2 in HuCCT1 cells. (PMID:23922722)
- Mir-376c, mapped to the 14q32.31 locus, regulates proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. (PMID:24166498)
- miR-376c levels were differentially expressed by race and PAR4 reactivity and were inversely correlated with PCTP mRNA levels, PC-TP protein levels and PAR4 reactivity. (PMID:24216752)
- microRNA 376c (miR-376c) significantly enhanced neural differentiation of hPSCs in a defined condition by suppressing SMAD4 (PMID:25114173)
- miR-638 plays an important role in triple-negative breast cancer progression via BRCA1 deregulation. (PMID:25228385)
- Expression of UGT2B15 and UGT2B17 is negatively regulated by the binding of miR-376c. (PMID:26163549)
- miR-376c is inversely linked to UGT2B15 and UGT2B17 expression in high-grade prostate cancer and metastasis.UGT2B15 and UGT2B17 genes are direct targets of miR-376c and thus may influence steroid metabolism during prostate cancer progression. (PMID:26385605)
- miR-376c inhibits non-small-cell lung cancer cell growth and invasion by targeting LRH-1 (PMID:27049310)
- newly identified miR-376c/BMI1 pathway provides an insight into cervical cancer progression (PMID:27345009)
- our results defined a novel pathway in which dysregulation of the RUNX2/INHBA axis due to miR-376c downregulation fosters lymph node metastasis in head and neck squamous cell carcinoma (PMID:27760788)
- TSP-2 enhances the migration of PCa cells by increasing MMP-2 expression through down-regulation of miR-376c expression. (PMID:28122633)
- MiR-376c-3p suppresses the fission, proliferation, migration and invasion and induces cell apoptosis of oral squamous cancer cells via targeting HOXB7. (PMID:28482289)
- results demonstrate that miR-376c functions by suppressing ARID4A expression, which in turn enhances the oncogenicity of gastric carcinoma cells. It seems likely that the level of miR-376c in plasma and urine could act as invaluable markers for the detection of gastric carcinoma (PMID:28486502)
- over-expression of miR-638 inhibited the activation of Wnt/beta-catenin signaling pathway. (PMID:29271990)
- that DLX6-AS1 may contribute to preeclampsia by impairing proliferative, migratory and invasive abilities of trophoblasts via the miR-376c/GADD45A axis (PMID:30055134)
- we have identified miR-376c-3p as a TWIST-1-regulated miRNA, which plays an important role in the osteogenesis of bone precursor cells and can mediate TWIST-1 inhibition of osteogenesis. (PMID:30229694)
- The data suggest that miR-376c-3p downregulated ING5 to exert protective effects against oxygen-glucose deprivation-induced cell injury in cultured human and rat cells. (PMID:31844418)
- Age-Related Changes in miRNA Expression Influence GSTZ1 and Other Drug Metabolizing Enzymes. (PMID:32357971)
- CircEXOC6B Suppresses the Proliferation and Motility and Sensitizes Ovarian Cancer Cells to Paclitaxel Through miR-376c-3p/FOXO3 Axis. (PMID:33006481)
- Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1. (PMID:33280517)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.